Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Imidazol-2-ylidene-Based NCCN Ligands for Chiral-at-Iron Catalysis.

Organometallics·2026

Same author

Asymmetric Iron-Catalyzed Vicinal C(sp<sup>3</sup>)─H Diamination of Carboxylic Acids.

Angewandte Chemie (International ed. in English)·2026

Same author

The role of KDM5B in creating synthetic vulnerabilities in combination with radiotherapy in melanoma cells.

Cell communication and signaling : CCS·2026

Same author

An Achiral Tetradentate Cis-α-Coordinating NCCN Ligand Gives Rise to a Configurationally Stable Chiral-at-Iron Complex for Enantioselective Catalysis.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025

Same author

Cobalt catalyst with exclusive metal-centered chirality for asymmetric photocatalysis.

Nature communications·2025

Same author

Plasmid-driven strategies for clone success in Escherichia coli.

Nature communications·2025

Search research articles

Related Experiment Video

Updated: May 12, 2026

ARL Spectral Fitting as an Application to Augment Spectral Data via Franck-Condon Lineshape Analysis and Color Analysis

ARL Spectral Fitting as an Application to Augment Spectral Data via Franck-Condon Lineshape Analysis and Color Analysis

Published on: August 19, 2021

Rhenium complexes with visible-light-induced anticancer activity.

Anja Kastl¹, Sandra Dieckmann, Kathrin Wähler

¹Fachbereich Chemie, Philipps-Universität Marburg, Marburg, Germany.

|April 10, 2013

Summary

This summary is machine-generated.

New rhenium(I) indolato complexes show potent visible-light-activated antiproliferative effects against cancer cells. This activity stems from efficient singlet oxygen generation, leading to apoptosis.

More Related Videos

Line Shape Analysis of Dynamic NMR Spectra for Characterizing Coordination Sphere Rearrangements at a Chiral Rhenium Polyhydride Complex

Line Shape Analysis of Dynamic NMR Spectra for Characterizing Coordination Sphere Rearrangements at a Chiral Rhenium Polyhydride Complex

Published on: July 27, 2022

A Novel Technique for Generating and Observing Chemiluminescence in a Biological Setting

A Novel Technique for Generating and Observing Chemiluminescence in a Biological Setting

Published on: March 9, 2017

Related Experiment Videos

Last Updated: May 12, 2026

ARL Spectral Fitting as an Application to Augment Spectral Data via Franck-Condon Lineshape Analysis and Color Analysis

ARL Spectral Fitting as an Application to Augment Spectral Data via Franck-Condon Lineshape Analysis and Color Analysis

Published on: August 19, 2021

Line Shape Analysis of Dynamic NMR Spectra for Characterizing Coordination Sphere Rearrangements at a Chiral Rhenium Polyhydride Complex

Line Shape Analysis of Dynamic NMR Spectra for Characterizing Coordination Sphere Rearrangements at a Chiral Rhenium Polyhydride Complex

Published on: July 27, 2022

A Novel Technique for Generating and Observing Chemiluminescence in a Biological Setting

A Novel Technique for Generating and Observing Chemiluminescence in a Biological Setting

Published on: March 9, 2017

Area of Science:

Inorganic Chemistry
Photochemistry
Cancer Biology

Background:

Rhenium(I) complexes are explored for photodynamic therapy.
Developing targeted cancer therapies with external triggers is crucial.

Purpose of the Study:

To synthesize and characterize novel rhenium(I) indolato complexes.
To evaluate their visible-light-triggered antiproliferative activity.
To elucidate the mechanism of action, focusing on reactive oxygen species generation.

Main Methods:

Synthesis and spectroscopic characterization of rhenium(I) indolato complexes.
In vitro antiproliferative assays in 2D and 3D cancer cell cultures under visible light and dark conditions.
Analysis of singlet oxygen generation using appropriate probes.
Assessment of cellular morphological changes and apoptosis induction.

Main Results:

Rhenium(I) indolato complexes exhibit highly potent visible-light-triggered antiproliferative activity.
Complex 1 demonstrated significant activity (EC50 light=0.1 μM) compared to dark conditions (EC50 dark=100 μM).
The antiproliferative effect is attributed to efficient singlet oxygen generation, leading to rapid morphological changes and apoptosis.

Conclusions:

Novel rhenium(I) indolato complexes are effective visible-light-activated anticancer agents.
The mechanism involves photogenerated singlet oxygen, inducing cancer cell death.
These findings support the development of rhenium-based photodynamic anticancer therapies.